GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 39 filers reported holding GENOCEA BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,465,000 | +7.7% | 1,972,056 | 0.0% | 0.26% | -2.3% |
| Q4 2021 | $2,288,000 | -39.6% | 1,972,056 | 0.0% | 0.26% | -43.0% |
| Q3 2021 | $3,786,000 | -18.0% | 1,972,056 | 0.0% | 0.46% | -13.8% |
| Q2 2021 | $4,615,000 | -13.6% | 1,972,056 | 0.0% | 0.54% | -2.0% |
| Q1 2021 | $5,344,000 | +12.0% | 1,972,056 | 0.0% | 0.55% | +5.8% |
| Q4 2020 | $4,772,000 | +192.9% | 1,972,056 | +177.1% | 0.52% | +182.0% |
| Q3 2020 | $1,629,000 | -0.5% | 711,552 | 0.0% | 0.18% | +22.8% |
| Q2 2020 | $1,637,000 | +33.7% | 711,552 | 0.0% | 0.15% | -33.5% |
| Q1 2020 | $1,224,000 | -19.3% | 711,552 | -2.9% | 0.22% | -2.2% |
| Q4 2019 | $1,517,000 | -23.8% | 733,050 | +6.8% | 0.23% | -2.6% |
| Q3 2019 | $1,990,000 | -23.8% | 686,222 | +3.0% | 0.24% | -8.6% |
| Q2 2019 | $2,612,000 | – | 666,222 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,765,901 | $4,273,000 | 2.32% |
| NEA Management Company, LLC | 10,376,936 | $25,112,000 | 0.66% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $478,000 | 0.62% |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $908,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,772,000 | 0.52% |
| BVF INC/IL | 4,012,404 | $9,710,000 | 0.38% |
| Avoro Capital Advisors LLC | 5,084,184 | $12,304,000 | 0.21% |
| FNY Investment Advisers, LLC | 200,000 | $484,000 | 0.13% |
| Boxer Capital, LLC | 1,134,453 | $2,745,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,745 | $316,000 | 0.05% |